|
000
| 01322cas 2200277za 4500 |
|---|
| 001 | 9.825672 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20230705113321 |
|---|
| 007 | cr ||||||||||| |
|---|
| 008 | 161011c20169999oncar p o f0 a0eng|d |
|---|
| 022 | |a2371-5154 |
|---|
| 040 | |aCaOODSP|beng |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aH79-10E-PDF |
|---|
| 222 | 0|aMarket intelligence report |b(Ottawa) |
|---|
| 245 | 00|aMarket intelligence report |h[electronic resource]. |
|---|
| 260 | |aOttawa : |bPatented Medicine Prices Review Board, |c2016- |
|---|
| 310 | |aAnnual |
|---|
| 362 | 1 |aBegan with 2015. |
|---|
| 500 | |aIssued also in French under title: Situation du marché, rapport. |
|---|
| 500 | |aEach issue has a distinctive title. |
|---|
| 520 | |a"This series provides detailed information on specific therapeutic market segments of importance to Canadians. These targeted analyses are designed to inform policy discussions, aid in evidence-based decision making, and provide Canadians with a more comprehensive view of issues pertaining to pharmaceutical drug pricing and utilization in Canada and internationally."|uhttp://pmprb-cepmb.gc.ca/en/npduis/research-agenda |
|---|
| 692 | 07|2gccst|aPatented medicine |
|---|
| 692 | 07|2gccst|aMarket analysis |
|---|
| 710 | 1 |aCanada. |bPatented Medicine Prices Review Board. |
|---|
| 775 | 08|tRapport sur la situation du marché |w(CaOODSP)9.825673 |
|---|